Paper40887304
Gout, Uric Acid, and Coronary Artery Disease.
Nakahashi T and 3 others. J Atheroscler Thromb, 2025. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Gout, Uric Acid, and Coronary Artery Disease. Papers, record 40887304. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40887304
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Artery Disease | Major topic |
| Uric Acid | Major topic |
| Gout | Major topic |
| Hyperuricemia | Major topic |
| Humans | |
| Risk Factors | |
| Biomarkers |
Source PubMed
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33,307,617 | Ultrasonography and dual-energy computed tomography: impact for the detection of gouty deposits. | Ultrasonography | 2021 | https://conductscience.org/library/papers/33307617 | PubMed |
| 2 | 38,220,209 | Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study. | J Atheroscler Thromb | 2024 | https://conductscience.org/library/papers/38220209 | PubMed |
| 3 | 35,013,022 | Statin Use Influence on the Occurrence of Acute Kidney Injury in Patients with Peripheral Arterial Disease. | J Atheroscler Thromb | 2022 | https://conductscience.org/library/papers/35013022 | PubMed |
| 4 | 30,723,999 | Association between J-CTO score and long-term target lesion revascularization rate after successful chronic total coronary occlusion angioplasty (from the J-CTO Registry). | Catheter Cardiovasc Interv | 2019 | https://conductscience.org/library/papers/30723999 | PubMed |
| 5 | 21,242,644 | The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention. | Circ J | 2011 | https://conductscience.org/library/papers/21242644 | PubMed |
| 6 | 39,529,973 | Imaging human coronary cholesterol/urate crystals with cross-polarized micro-optical coherence tomography. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/39529973 | PubMed |
| 7 | 16,251,237 | Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. | J Am Soc Nephrol | 2005 | https://conductscience.org/library/papers/16251237 | PubMed |
| 8 | 18,591,837 | Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. | Intern Med | 2008 | https://conductscience.org/library/papers/18591837 | PubMed |
| 9 | 25,282,685 | Serum concentrations of galectin-3 in patients with cardiac syndrome X. | Atherosclerosis | 2014 | https://conductscience.org/library/papers/25282685 | PubMed |
| 10 | 24,157,191 | Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents. | Am J Cardiol | 2014 | https://conductscience.org/library/papers/24157191 | PubMed |
| 11 | 33,181,081 | Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial. | Lancet | 2020 | https://conductscience.org/library/papers/33181081 | PubMed |
| 12 | 27,396,561 | Hyperuricemia and Atrial Fibrillation. | Int Heart J | 2016 | https://conductscience.org/library/papers/27396561 | PubMed |
| 13 | 28,665,063 | Uric Acid Level Has a U-shaped Association with Clinical Outcomes in Patients with Vasospastic Angina. | J Korean Med Sci | 2017 | https://conductscience.org/library/papers/28665063 | PubMed |
| 14 | 34,479,787 | Relationship between serum uric acid levels and the incidence of cardiovascular events after percutaneous coronary intervention. | J Cardiol | 2021 | https://conductscience.org/library/papers/34479787 | PubMed |
| 15 | 35,400,029 | The Association of Hyperuricemia and Gout With the Risk of Cardiovascular Diseases: A Cohort and Mendelian Randomization Study in UK Biobank. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/35400029 | PubMed |
| 16 | 27,665,399 | Hyperuricemia and contrast-induced acute kidney injury: A systematic review and meta-analysis. | Int J Cardiol | 2016 | https://conductscience.org/library/papers/27665399 | PubMed |
| 17 | 16,407,889 | Gout-associated uric acid crystals activate the NALP3 inflammasome. | Nature | 2006 | https://conductscience.org/library/papers/16407889 | PubMed |
| 18 | 35,589,464 | Impact of hyperuricemia on coronary blood flow and in-hospital mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention. | J Cardiol | 2022 | https://conductscience.org/library/papers/35589464 | PubMed |
| 19 | 30,242,335 | Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial. | Ann Intern Med | 2018 | https://conductscience.org/library/papers/30242335 | PubMed |
| 20 | 36,216,006 | Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial. | Lancet | 2022 | https://conductscience.org/library/papers/36216006 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,709,652 | Antithrombin in Hyperuricemic Nephropathy: Unveiling Its Noncanonical Renoprotective Roles and Therapeutic Repurposing Potential. | Kidney Blood Press Res | 2026 | https://conductscience.org/library/papers/42709652 | PubMed |
| 42,639,006 | Pediatric hyperuricemia: genetic basis, metabolic mechanisms, and clinical implications. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42639006 | PubMed |
| 42,370,995 | Uric acid and subclinical atherosclerosis: distinct associations across coronary and carotid arteries. | Clin Res Cardiol | 2026 | https://conductscience.org/library/papers/42370995 | PubMed |
| 41,566,481 | NMR-based metabolomics in a clinical cohort: deciphering the metabolic characteristics of gout with the dampness-heat syndrome and elucidate the efficacy of Simiao Pill. | Chin Med | 2026 | https://conductscience.org/library/papers/41566481 | PubMed |
| 41,302,958 | Hyperuricemia as an Early Indicator of Cardiovascular Risk in the General Population. | J Clin Med | 2025 | https://conductscience.org/library/papers/41302958 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CRP | 1,401 | PubTator's text mining | https://conductscience.org/library/genes/1401 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40887304
GET https://conductscience.org/api/papers/v1/40887304/references?page=2